CompanyGraph
Tempur Sealy International Inc.
TPX · NYSE Arca · United States
somnigroup.comFinancials as of FY2024 · latest on file
Makes mattresses from a heat-activated foam that softens under your body to relieve pressure in a way ordinary foam cannot.
- Depends onUpstream position: supplies 5 industries, depends on 0
- ScaleLevered free cash flow is higher than 95% of all stocks globally
- FinancialsAltman Z-Score: safe zone
- Interpretations6 currently firing — 6
What this company is and how it runs — written from structure, not news.
Tempur Sealy makes mattresses whose pressure-relieving properties come from a NASA-derived foam that softens at the exact points where body heat concentrates — a characteristic that is physically encoded during a temperature-controlled curing process, not added by design after the fact. Because the foam must hold precise thermal conditions for an extended setting period, the number of climate-controlled curing cells available sets a hard ceiling on how many mattresses the company can produce, and that ceiling cannot be raised by running faster or hiring more workers. The same thermal sensitivity then ripples forward through the supply chain: finished foam must be warehoused and shipped in temperature-regulated environments, or the molecular structure degrades before the mattress reaches the customer — a chain of requirements that competitors using standard polyurethane foam do not face and cannot replicate simply by copying the brand. The whole premium rests on that formulation remaining proprietary, so if a chemist or a court ever made the thermal-cure process available to outside manufacturers, the pressure-relieving performance would no longer be something only Tempur Sealy can sell.
How does this company make money?
The company earns money three ways. It sells mattresses wholesale to retail partners like Mattress Firm, keeping a wholesale margin on each unit. It sells directly to customers through its own stores and website, where it keeps the full retail price instead of sharing it with a retailer. It also collects licensing fees from hotels and healthcare facilities that buy commercial-grade Sealy and Tempur-Pedic products for professional use.
What makes this company hard to replace?
Mattress Firm stores are physically laid out and their sales staff trained specifically around Tempur-Pedic and Sealy product demonstrations, so switching brands would mean rebuilding that retail infrastructure from scratch. Hotel chains like Marriott are locked in further because changing bedding specifications requires going through lengthy requalification processes written into franchise agreements. Medical professionals who have built prescription relationships around specific Tempur-Pedic models for patient therapy would have to restart that process with a different product.
What limits this company?
The only way to make more mattresses is to add more climate-controlled curing cells — the sealed chambers where each batch of foam sets at exact temperatures. You cannot speed up the process or run extra shifts to get around it. The curing period takes as long as it takes, and shortening it changes the foam's behavior. Every production ceiling the company hits comes back to how many of those curing cells exist.
What does this company depend on?
The company cannot operate without its temperature-sensitive viscoelastic foam compounds, Leggett & Platt innerspring coil systems, climate-controlled manufacturing facilities, retail partnerships with Mattress Firm and other specialty bedding chains, and temperature-regulated trucking fleets that keep the foam stable during transport.
Who depends on this company?
Mattress Firm retail locations would lose their main premium mattress categories if Tempur-Pedic and Sealy supplies stopped. Marriott and other hospitality chains that use Sealy Posturepedic mattresses in guest rooms would face disruptions to their room upgrade programs. Sleep disorder clinics and medical professionals who prescribe specific Tempur-Pedic models for pressure point relief would lose access to those products.
How does this company scale?
Managing three brands — Tempur-Pedic, Sealy, and Stearns & Foster — across shared retail relationships and marketing infrastructure is relatively cheap to expand. What does not scale easily is the core foam expertise: the specialized knowledge of memory foam chemistry and the thermal manufacturing requirements cannot be automated or handed off, so that part of the operation stays a bottleneck even as the brand side grows.
What external forces can significantly affect this company?
Rising petroleum costs push up the price of polyurethane foam inputs, which squeezes margins on every mattress made. Federal Trade Commission labeling rules require specific disclosures about materials, which limits how the products can be marketed. An aging population drives more demand for therapeutic sleep products, but rising healthcare costs can pull back the same customers' willingness to spend on a premium mattress.
Where is this company structurally vulnerable?
If someone outside the company — through a successful legal challenge to the patents, a forced license, or a chemist who independently works out the thermal-cure process — managed to replicate the foam formulation, the product would no longer be something only this company can make. At that point, the premium price customers pay would rest entirely on marketing, and any manufacturer with climate-controlled equipment could make the same argument.
Price is read as structure — trend, levels, range, peak and volatility drawn on the chart. It does not predict where price goes next.
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
As of FY2024 (year ended December 31, 2024). Newer annual figures aren't yet on file.
6 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Debt Financing Activity
Three financing observations align: debt issuance is large relative to operating cash flow, absolute financing cash flow is large relative to operating cash flow, and long-term debt is a large share of total debt. Together they describe heavy financing activity with a long-term-debt-dominant mix.
How does this company use capital?
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Three observations describe the configuration: return on equity is elevated, debt-to-equity is high (industry-benchmarked), and the equity multiplier (Assets / Equity) is large. The DuPont identity (ROE = ROA × Equity Multiplier) means leverage mechanically amplifies whatever ROA the company is producing; the observations do not separate the two contributions.
Cumulative Treasury Stock Significant With Elevated ROE And FCF-To-Equity
Three observations have aligned: the cumulative treasury-stock balance is significant relative to current equity, return on equity sits in the upper industry-benchmarked peer range, and free cash flow as a share of equity book value is in the upper portion of its mapped range.
FCF Ratios Elevated
Three FCF-denominator ratios co-occur in their elevated ranges: FCF/total assets, FCF/total shareholders' equity, and industry-benchmarked FCF/OCF. The configuration describes free cash flow scaling against three different denominators at the latest annual snapshot.
How is this stock valued?
Close Below 40W SMA With Profitability
Three observations describe the present configuration: the current close sits below the 40-week SMA (the conventional 'below 200-day SMA'), the company has reported positive net income in each of the last three annual periods, and operating cash flow exceeded net income in the most recent annual period.
Where is this company structurally exposed?
Elevated Leverage on Three Denominators
Three leverage observations have converged at elevated readings: debt is large relative to equity, large relative to total assets, and large relative to trailing operating cash flow. The capital structure is leveraged on three different denominators at once.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Supply Chain
Scale
Companies that share the same coordination system — how they create, deliver, or capture value.
Companies that share active interpretations — structural patterns currently present in both stocks.